SPHERA FUNDS MANAGEMENT LTD. - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 23 filers reported holding PROQR THRAPEUTICS N V in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q1 2020$1,900,000
-76.2%
346,148
-57.0%
0.24%
-63.8%
Q4 2019$7,978,000
+51.4%
805,000
-12.0%
0.66%
-19.3%
Q3 2019$5,270,000
+23.2%
915,000
+94.7%
0.81%
+39.1%
Q2 2019$4,277,000
+62.3%
470,000
+147.4%
0.58%
+142.7%
Q1 2019$2,635,000
-50.9%
190,000
-44.1%
0.24%
-60.2%
Q4 2018$5,365,000
-30.5%
340,000
-14.7%
0.60%
-31.7%
Q3 2018$7,716,000
+114.1%
398,749
-19.2%
0.89%
+78.3%
Q2 2018$3,604,000
+78.0%
493,749
-25.0%
0.50%
+61.9%
Q1 2018$2,025,000
+18.5%
658,500
+24.2%
0.31%
+52.7%
Q4 2017$1,709,000
-33.5%
530,0000.0%0.20%
-45.2%
Q3 2017$2,571,000
+49.8%
530,000
+60.6%
0.37%
+25.7%
Q2 2017$1,716,000
+4.0%
330,0000.0%0.29%
-9.6%
Q1 2017$1,650,000
+68.4%
330,000
+65.0%
0.32%
+30.2%
Q4 2016$980,000
-24.7%
200,000
+33.3%
0.25%
+29.8%
Q4 2015$1,302,000
-53.8%
150,000
+15.4%
0.19%
-60.2%
Q4 2014$2,817,000
-18.1%
130,000
-35.0%
0.48%
+12.9%
Q3 2014$3,438,000200,0000.42%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q4 2016
NameSharesValueWeighting ↓
Privium Fund Management B.V. 5,344,446$4,156,0001.38%
Prosight Management, LP 1,707,509$1,328,0001.05%
Opaleye Management Inc. 2,740,000$2,131,0000.96%
M28 Capital Management LP 1,001,800$779,0000.87%
Monaco Asset Management SAM 931,400$724,0000.32%
APOGEM CAPITAL LLC 125,273$97,0000.09%
Ground Swell Capital, LLC 21,640$17,0000.03%
FRANKLIN STREET ADVISORS INC /NC 150,000$117,0000.01%
Atom Investors LP 30,422$24,0000.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,300,000$2,566,0000.01%
View complete list of PROQR THRAPEUTICS N V shareholders